Clinical Trial

Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects

Name: Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects — clinical trial record (NCT05844293)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate safety, tolerability, PK, and PD of SAD of FXI-GalNAc-siRNA administered SC to healthy subjects.

Trial Details

NCT Number	NCT05844293
Lead Sponsor	Sirnaomics
Conditions	FXI
Enrollment	40 participants
Start Date	2023-05-16
Primary Completion	2027-05 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-29